A 2-Gene Host Signature for Improved Accuracy of COVID-19 Diagnosis Agnostic to Viral Variants

Jack Albright; Eran Mick; Estella Sanchez-Guerrero; Jack Kamm; Anthea Mitchell; Angela M Detweiler; Norma Neff; Alexandra Tsitsiklis; Paula Hayakawa Serpa; Kalani Ratnasiri; Diane Havlir; Amy Kistler; Joseph DeRisi; Angela Oliveira Pisco; Charles Langelier.
Preprint en Inglés | PREPRINT-MEDRXIV | ID: ppmedrxiv-21268498

Documentos relacionados

  1. A 2-Gene Host Signature for Improved Accuracy of COVID-19 Diagnosis Agnostic to Viral Variants.
  2. SARS-CoV-2 variants evolve convergent strategies to remodel the host response.
  3. Highly sensitive extraction-free saliva-based molecular assay for rapid diagnosis of SARS-CoV-2.
  4. Convolutional Neural Network Applied to SARS-CoV-2 Sequence Classification.
  5. The Life of SARS-CoV-2 Inside Cells: Replication-Transcription Complex Assembly and Function.
  6. Deep mutational learning predicts ACE2 binding and antibody escape to combinatorial mutations in the SARS-CoV-2 receptor-binding domain.
  7. Multi-omics analysis of mucosal and systemic immunity to SARS-CoV-2 after birth.
  8. Diagnostic power of one-step and two-step RT-qPCR methods to SARS­CoV­2 detection.
  9. Structural Study of SARS-CoV-2 Antibodies Identifies a Broad-Spectrum Antibody That Neutralizes the Omicron Variant by Disassembling the Spike Trimer.
  10. Remdesivir and GS-441524 Retain Antiviral Activity against Delta, Omicron, and Other Emergent SARS-CoV-2 Variants.